Pay in 4 interest-free payments of $5.56 Learn more
Ships within 48 hours · Estimated delivery Sep 4 - Sep 9
A review published in MDPI Biomolecules supports Freya Meds use of GLP-1 treatments, noting that these medications help regulate appetite, promote weight reduction, and improve long-term metabolic balance [2]
It mimics the incretin hormone GLP-1 to enhance glucose-dependent insulin secretion, suppress glucagon, slow gastric emptying, and reduce appetite through central pathways
The pen delivers the full dose with a button press
Eli Lilly has an oral candidate in Phase 2 trials, with the earliest realistic approval timeline in late 2027 or 2028
Zhang C, Gao L, Wu D, Wang G, Lan H, Li L, et al
US$ 25.59
US$ 29.77
US$ 28.59
US$ 25.68
US$ 21.57
US$ 21.49
